Clinical Trial Update: Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating whether methotrexate polyglutamate levels correlate with clinical outcomes in rheumatoid arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2011-02-15